Clinical Trials Browser

Phase EARLY_PHASE1 × Neoplastic Cells, Circulating × osimertinib × Clear all

NCT06557096 2024-08-16

CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC

Phase EARLY_PHASE1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating